How Trump’s victory could change abortion rights in America

Anti-abortion demonstrators listen to President Donald Trump as he speaks at the 47th annual “March for Life” in Washington, D.C., Jan. 24, 2020. Olivier Douliery | Afp | Getty Images Voters in seven out of 10 states approved ballot measures this week to safeguard abortion rights, a hot-button issue that helped drive Americans to the…

Weight loss drug race heats up with obesity pill data

Aykut Karahan | Istock | Getty Images A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. Happy Friday! Buried in the election news this week was new data from drugmakers vying to enter the booming weight…

Apple won’t launch a smart ring, says Oura CEO: ‘It’s hard to do’

The Oura Ring 4. Courtesy: Oura LISBON — Apple will not introduce a smart ring, the CEO of health-tech firm Oura told CNBC, despite speculation the iPhone giant may be considering a move into this product category. Samsung’s smart ring debut earlier this year has put the product firmly in the spotlight, with one analyst…

Amgen stock falls on weight loss drug’s bone density loss data

Shares of Amgen fell more than 7% Tuesday as analysts chewed over bone density loss data from an early-stage trial on its experimental weight loss injection, MariTide. One analyst said the additional data suggests a new potential safety risk tied to the drug. But others said the share move was an overreaction, and that more…

Alopecia and me: ‘I embrace it, but I’d love my old hair back’

People living with one of the most common types of alopecia could soon have access to treatment on the NHS in Scotland for the first time. The drug – called Ritlecitinib – will go before the Scottish Medicines Consortium this week after it was approved for NHS use in England last month. Although the daily…

End of content

End of content